We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Glythera Collaborates With Cancer Research UK to Develop Next-Generation Antibody Drug Conjugate

Product News   Sep 26, 2017

 
Glythera Collaborates With Cancer Research UK to Develop Next-Generation Antibody Drug Conjugate

Image Credit: Glythera

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

LegoChem Biosciences and Iksuda Enter Licensing Agreement for Antibody Drug Conjugate Program

Product News

LegoChem Biosciences, Inc. (LCB) has announced a worldwide license agreement with Iksuda Therapeutics for the development and commercialization of LCB73, a CD19-targeted ADC candidate for hematological tumors.

READ MORE

Thermo Fisher Scientific and Q2 Solutions Partner to Deliver Clinical Trial Results Faster

Product News

Q2 Solutions has announced its partnership with Thermo Fisher Scientific to deliver clinical trial lab results economically with unprecedented speed.

READ MORE

Mission Bio Launches Cloud-based Tool to Improve CRISPR Safety

Product News

Mission Bio has extended capabilities for its automated, cloud-based tool for designing targeted single-cell DNA custom panels, now with applications across mouse genomes and CRISPR editing.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE